Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

NCT03777410 · clinicaltrials.gov ↗
TERMINATED
Status
33
Enrollment
INDUSTRY
Sponsor class

Stopped Insufficient pace of enrollment due to changes in MM SOC practices

Conditions

Sponsor

Travera Inc

Collaborators